Skip to main content

Table 1 Overview of outcome measures

From: A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark

Outcome measure

Target population

Cases (N)

Target threshold (%)

Fulfilment

Target threshold achieved

1. Screening for PAVM

All HHT-patients

180

≥ 90

100% (n = 180)

Yes

2. Written advice on epistaxis

All HHT-patients with epistaxis

151

≥ 90

66% (n = 99)1

26% (n = 40)2

40% (n = 59)3

No

3. Iron deficiency anaemia assessment

All HHT-patients and ≥ 12 years old

167

≥ 70

80% (n = 133)

Yes

4. Written advice on AB

All HHT patients, except 9 patients where PAVM was ruled out

171

100

75% (n = 129)1

32% (n = 55)2

43% (n = 74)3

No

5. Written advice about pregnancy

All HHT-patients, and female ≥ 15 and ≤ 45 years old

45

100

80% (n = 36)1

24% (n = 11)2

56% (n = 25)3

No

  1. 1Patients received written advice, or the patients were thoroughly informed
  2. 2Patients received written advice
  3. 3Patients were thoroughly informed